文献速递神经MR

超越全切:深部瘤周影像组学预测胶质母细胞瘤总生存与MGMT启动子甲基化状态

Beyond gross total resection (GTR): Deep peritumoral radiomics for predicting overall survival (OS) and O6-methylguanine-DNA-methyltransferase promoter methylation (MGMTpm) status in glioblastoma multiforme.
PubMed 文献 · Neuroradiology · 2026-05-18

本研究基于520例和200例胶质母细胞瘤患者的多参数MRI,提取肿瘤及不同范围瘤周区域的深度影像组学特征,用于预测总生存期和MGMT启动子甲基化状态。结果显示,纳入8 mm瘤周边缘使OS预测AUC从0.74提升至0.76;联合10 mm瘤周区域使MGMTpm预测AUC达0.81,优于仅肿瘤模型(AUC 0.71)。

要点

  • 瘤周区域携带预后和分子信息,联合肿瘤可提升预测效能。
  • OS预测最佳瘤周边缘为8 mm,MGMTpm预测最佳为10 mm。
  • 术前MRI深度影像组学可无创预测MGMTpm,辅助化疗决策。

核心结论

  • 瘤周区域编码预后和分子信息,整合瘤周区域可提升影像组学对总生存和MGMT启动子甲基化状态的预测能力。

研究设计与样本

  • 回顾性分析多参数结构MRI(T1、T1-Gd、T2、T2-FLAIR)的胶质母细胞瘤患者,OS预测520例、MGMTpm预测200例。
  • 肿瘤和瘤周掩膜经形态学膨胀2至12 mm生成,使用ResNet50和ViT-B16提取每例约11000个深度特征。
  • 采用方差阈值和递归特征消除进行混合特征选择(含年龄和性别),以支持向量机分类器进行10折交叉验证。

诊断标准与关键数值

  • OS预测:纳入8 mm瘤周边缘使AUC从0.74(95%CI 0.69-0.80)提升至0.76(95%CI 0.71-0.80)。
  • MGMTpm预测:肿瘤联合10 mm瘤周边缘AUC最高为0.81(95%CI 0.77-0.86),优于仅肿瘤模型AUC 0.71(95%CI 0.65-0.77)。

临床应用与阅片要点

  • 术前MRI评估胶质母细胞瘤时,应关注瘤周区域而非仅肿瘤强化区,瘤周8-10 mm范围对预后和分子分型有附加价值。
  • 影像组学模型可无创提示MGMT启动子甲基化状态,有望辅助化疗决策,减少活检采样偏差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND & OBJECTIVE: Glioblastoma Multiforme (GBM) is an aggressive and highly heterogeneous brain tumor with poor survival outcomes. While conventional radiomic analyses focus on tumor-centric regions, emerging surgical strategies, such as GTR and supratotal resection (SupTR), highlight the importance of the peritumoral zone. Moreover, due to intratumoral heterogeneity, MGMTpm, a key molecular biomarker guiding chemotherapeutic decisions, is assessed invasively and remains prone to sampling bias. Therefore, this study examined the prognostic and predictive utility of deep radiomic features from tumor and peritumoral regions in preoperative MRI to improve OS prediction and enable non-invasive MGMTpm classification.

METHODS: Multi-parametric structural MRI scans (T1, T1-Gd, T2, and T2-FLAIR) from 520 to 200 GBM patients were analyzed for OS and MGMTpm prediction, respectively. Tumor and peritumoral masks were segmented and expanded using morphological dilation from 2 to 12 mm. ~11,000 deep features per patient were extracted using ResNet50 and ViT-B16 models, capturing patterns that may reflect tumor infiltration and microenvironmental changes. Hybrid feature selection using variance thresholding and Recursive Feature Elimination (RFE) was applied, including age and gender. Support Vector Machine (SVM) classifiers were trained using 10-fold cross-validation.

RESULTS: In OS prediction, the inclusion of an 8 mm peritumoral margin improved AUC from 0.74 (95% CI: 0.69-0.80) to 0.76 (95% CI: 0.71-0.80). For MGMTpm prediction, combining tumor with a 10 mm peritumoral margin achieved the highest AUC of 0.81 (95% CI: 0.77-0.86), surpassing tumor-only models (AUC 0.71, 95% CI: 0.65-0.77).

CONCLUSION: Peritumoral regions encode prognostic and molecular information. Integrating these regions enhances radiomics-based prediction of survival and MGMTpm status, supporting their role in non-invasive precision GBM management.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Prasad S, Saini J, Dubey NK, et al. Beyond gross total resection (GTR): Deep peritumoral radiomics for predicting overall survival (OS) and O6-methylguanine-DNA-methyltransferase promoter methylation (MGMTpm) status in glioblastoma multiforme. Neuroradiology. 2026. PMID: 42149212. doi:10.1007/s00234-026-04016-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。